RESULTS FROM A QUANTITATIVE MRI-BASED APPROACH Alexander Seiler 1 , Marlies Wagner 2 , Niklas Helwig 2 1 University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany, 2 Frankfurt University Hospital (Goethe University), Frankfurt, Germany Background and Aims: Findings on the association between cerebral small vessel disease (CSVD) and pial collaterals in patients with large-vessel occlusion (LVO) have been inconsistent
Symptoms may include: stomach area swelling fullness, gas in the stomach area abdominal pain and cramping breath odor constipation diarrhea inability to pass gas vomiting What to do If you experience stomach side effects with this medicine that bother you, worsen or do not go away, call your healthcare provider right away for further evaluation
These discrepancies may arise from variations in sample sizes and the methods used to measure GLP-1 hormones, as well as poor medication reporting during data collection
If nausea interferes with adherence, your healthcare provider can modify your starting dose, escalation timeline, or recommend an alternative compounded option like oral semaglutide, which some patients tolerate better
